Revenue
$4.82B
Gross Margin
+61.8%
Operating Margin
+21.4%
Net Margin
+19.3%
Income statement waterfall for DexCom (DXCM) — TTM through Q1 2026
Net income: $930.40M
Margin breakdown for DexCom (DXCM) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $4.82B | $4.82B |
| Cost of Revenue | −$1.84B | $2.98B |
| Gross Profit | $2.98B | $2.98B |
| Operating Expenses | −$1.95B | $1.03B |
| Operating Income | $1.03B | $1.03B |
| Other Income / Expense | $170.20M | $1.20B |
| Pre-tax Income | $1.20B | $1.20B |
| Income Tax | −$273.20M | $930.40M |
| Net Income | $930.40M | $930.40M |
- Revenue$4.82B
- Cost of Revenue−$1.84B
- Gross Profit$2.98B
- Operating Expenses−$1.95B
- Operating Income$1.03B
- Other Income / Expense$170.20M
- Pre-tax Income$1.20B
- Income Tax−$273.20M
- Net Income$930.40M
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement